The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Coronary Microvascular Dysfunction and Prognosis in Hypertrophic Cardiomyopathy
Abstract
BACKGROUND: Microvascular dysfunction, reflected by an inadequate increase in myocardial blood flow in response to dipyridamole infusion, is a recognized feature of hypertrophic cardiomyopathy. Its long-term effect on the prognosis is unknown. We prospectively evaluated a cohort of patients with hypertrophic cardiomyopathy after they had undergone quantitative assessment of myocardial blood flow by positron-emission tomography (PET). METHODS: Fifty-one patients (New York Heart Association class I or II) were followed for a mean (+/-SD) of 8.1+/-2.1 years after PET. Twelve subjects with atypical chest pain served as controls. Measurement of flow was performed at base line and after the infusion of the coronary vasodilator dipyridamole, with the use of nitrogen-13-labeled ammonia. Patients were then divided into three equal groups with increasing values of myocardial blood flow. RESULTS: The response of myocardial blood flow to dipyridamole was severely blunted in the patients, as compared with the controls (1.50+/-0.69 vs. 2.71+/-0.94 ml per minute per gram of tissue, P<0.001). Sixteen patients (31 percent) had an unfavorable outcome (death from cardiovascular causes, progression to New York Heart Association class III or IV, or sustained ventricular arrhythmias requiring the implantation of a cardioverter-defibrillator) 2.2 to 9.1 years after PET. Reduced blood flow in response to dipyridamole was strongly associated with an unfavorable outcome. Multivariate analysis showed that among patients in the lowest of the three flow groups the age-adjusted relative hazard of death from cardiovascular causes was 9.6 (P=0.02) and the relative hazard of an unfavorable outcome (a combined end point) was 20.1 (P=0.003), as compared with patients in the two other flow groups. Specifically, all four patients who died from heart failure and three of five who died suddenly were in this subgroup. CONCLUSIONS: In patients with hypertrophic cardiomyopathy, the degree of microvascular dysfunction is a strong, independent predictor of clinical deterioration and death. Severe microvascular dysfunction is often present in patients with mild or no symptoms and may precede clinical deterioration by years.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hypertrophic Cardiomyopathy: A Systematic Review
Maron, B. J. (2002) · JAMA · doi:10.1001/jama.287.10.1308 · Cited by 2,224
Maron, M. S., Olivotto, I., Betocchi, S., Casey, S. A., Lesser, J. R., Losi, M. A., Cecchi, F., & Maron, B. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021332 · Cited by 1,259
Self-citationMagnitude of Left Ventricular Hypertrophy and Risk of Sudden Death in Hypertrophic Cardiomyopathy
Spirito, P., Bellone, P., Harris, K. M., Bernabò, P., Bruzzi, P., & Maron, B. J. (2000) · New England Journal of Medicine · doi:10.1056/nejm200006153422403 · Cited by 1,143
The Management of Hypertrophic Cardiomyopathy
Spirito, P., Seidman, C. E., McKenna, W. J., & Maron, B. J. (1997) · New England Journal of Medicine · doi:10.1056/nejm199703133361107 · Cited by 1,007
Sudden death in hypertrophic cardiomyopathy: identification of high risk patients
Elliott, P. M., Poloniecki, J., Dickie, S., Sharma, S., Monserrat, L., Varnava, A., Mahon, N. G., & McKenna, W. J. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)01003-2 · Cited by 978
Maron, B. J., Shen, W.-K., Link, M. S., Epstein, A. E., Almquist, A. K., Daubert, J. P., Bardy, G. H., Favale, S., Rea, R. F., Boriani, G., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200002103420601 · Cited by 832
Intramural (“small vessel”) coronary artery disease in hypertrophic cardiomyopathy
Maron, B. J., Wolfson, J. K., Epstein, S. E., & Roberts, W. C. (1986) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(86)80181-4 · Cited by 756
Impact of Atrial Fibrillation on the Clinical Course of Hypertrophic Cardiomyopathy
Olivotto, I., Cecchi, F., Casey, S. A., Dolara, A., Traverse, J. H., & Maron, B. J. (2001) · Circulation · doi:10.1161/hc4601.097997 · Cited by 745
Self-citationMaron, B. J., Olivotto, I., Spirito, P., Casey, S. A., Bellone, P., Gohman, T. E., Graham, K. J., Burton, D. A., & Cecchi, F. (2000) · Circulation · doi:10.1161/01.cir.102.8.858 · Cited by 677
Self-citationMaron, B. J., Gottdiener, J. S., & Epstein, S. E. (1981) · The American Journal of Cardiology · doi:10.1016/0002-9149(81)90068-0 · Cited by 607
Elliott, P. M., Gimeno Blanes, J. R., Mahon, N. G., Poloniecki, J. D., & McKenna, W. J. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04005-8 · Cited by 518
Cannon, R. O., Rosing, D. R., Maron, B. J., Leon, M. B., Bonow, R. O., Watson, R. M., & Epstein, S. E. (1985) · Circulation · doi:10.1161/01.cir.71.2.234 · Cited by 477
Prognostic Role of Myocardial Blood Flow Impairment in Idiopathic Left Ventricular Dysfunction
Neglia, D., Michelassi, C., Trivieri, M. G., Sambuceti, G., Giorgetti, A., Pratali, L., Gallopin, M., Salvadori, P., Sorace, O., Carpeggiani, C., et al. (2002) · Circulation · doi:10.1161/hc0202.102119 · Cited by 448
Basso, C. (2000) · Human Pathology · doi:10.1053/hupa.2000.16659 · Cited by 418
Rajappan, K., Rimoldi, O. E., Dutka, D. P., Ariff, B., Pennell, D. J., Sheridan, D. J., & Camici, P. G. (2002) · Circulation · doi:10.1161/hc0402.102931 · Cited by 358
Self-citationCamici, P., Chiriatti, G., Lorenzoni, R., Bellina, R. C., Gistri, R., Italiani, G., Parodi, O., Salvadori, P. A., Nista, N., Papi, L., et al. (1991) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(91)90869-b · Cited by 337
Self-citationTanaka, M., Fujiwara, H., Onodera, T., Wu, D. J., Hamashima, Y., & Kawai, C. (1986) · Heart · doi:10.1136/hrt.55.6.575 · Cited by 313
Cecchi, F., Olivotto, I., Montereggi, A., Santoro, G., Dolara, A., & Maron, B. J. (1995) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(95)00353-3 · Cited by 296
Self-citationDilsizian, V., Bonow, R. O., Epstein, S. E., & Fananapazir, L. (1993) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(93)90193-5 · Cited by 279
O'Gara, P. T., Bonow, R. O., Maron, B. J., Damske, B. A., Van Lingen, A., Bacharach, S. L., Larson, S. M., & Epstein, S. E. (1987) · Circulation · doi:10.1161/01.cir.76.6.1214 · Cited by 265
Krams, R., Kofflard, M. J. M., Duncker, D. J., Von Birgelen, C., Carlier, S., Kliffen, M., Cate, F. J. T., & Serruys, P. W. (1998) · Circulation · doi:10.1161/01.cir.97.3.230 · Cited by 210
McKenna, W. J., Stewart, J. T., Nihoyannopoulos, P., McGinty, F., & Davies, M. J. (1990) · Heart · doi:10.1136/hrt.63.5.287 · Cited by 168
Udelson, J. E., Bonow, R. O., O'Gara, P. T., Maron, B. J., Van Lingen, A., Bacharach, S. L., & Epstein, S. E. (1989) · Circulation · doi:10.1161/01.cir.79.5.1052 · Cited by 165
Cannon, R. O., Dilsizian, V., O'Gara, P. T., et al. (1991) · Circulation · doi:10.1161/01.cir.83.5.1660 · Cited by 164
Olivotto, I., Gistri, R., Petrone, P., Pedemonte, E., Vargiu, D., & Cecchi, F. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02713-4 · Cited by 161
Self-citationSchwartzkopff, B., Mundhenke, M., & Strauer, B. E. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00036-9 · Cited by 154
Cardiac arrest in an adolescent with atrial fibrillation and hypertrophic cardiomyopathy
Stafford, W. J., Trohman, R. G., Bilsker, M., Zaman, L., Castellanos, A., & Myerburg, R. J. (1986) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(86)80484-3 · Cited by 129
Choudhury, L., Rosen, S. D., Patel, D. J., Nihoyannopoulos, P., & Camici, P. G. (1997) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a015090 · Cited by 99
Self-citationEffect of verapamil on absolute myocardial blood flow in hypertrophic cardiomyopathy
Gistri, R., Cecchi, F., Choudhury, L., Montereggi, A., Sorace, O., Salvadori, P. A., & Camici, P. G. (1994) · The American Journal of Cardiology · doi:10.1016/0002-9149(94)90404-9 · Cited by 91
Self-citationLazzeroni, E., Picano, E., Morozzi, L., Maurizio, A. R., Palma, G., Ceriati, R., Iori, E., Barilli, A. L., & (EPIC) Study Group, S. H. C. ;. (1997) · Circulation · doi:10.1161/01.cir.96.12.4268 · Cited by 75
Transmural myocardial blood flow distribution in hypertrophic cardiomyopathy and effect of treatment
Choudhury, L., Elliot, P. M., Rimoldi, O. E., Ryan, M., Lammertsma, A. A., Boyd, H., McKenna, W. J., & Camici, P. G. (1999) · Basic Research in Cardiology · doi:10.1007/s003950050126 · Cited by 73
Self-citationLorenzoni, R., Gistri, R., Cecchi, F., Olivotto, I., Chiriatti, G., Elliot, P. M., McKenna, W. J., & Camici, P. G. (1998) · American Heart Journal · doi:10.1016/s0002-8703(98)70152-8 · Cited by 71
Self-citationElliot, P. M., Kaski, J. C., Prasad, K., Seo, H., Slade, A., Goldman, J. H., & McKenna, W. J. (1996) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a015002 · Cited by 71
Cited by
Gersh, B. J., Maron, B. J., Bonow, R. O., Dearani, J. A., Fifer, M. A., Link, M. S., Naidu, S. S., Nishimura, R. A., Ommen, S. R., Rakowski, H., et al. (2011) · Circulation · doi:10.1161/cir.0b013e318223e2bd · Cited by 2,104
Coronary Microvascular Dysfunction
Camici, P. G., & Crea, F. (2007) · New England Journal of Medicine · doi:10.1056/nejmra061889 · Cited by 1,605
Self-citationMaron, B. J., McKenna, W. J., Danielson, G. K., Kappenberger, L. J., Kuhn, H. J., Seidman, C. E., Shah, P. M., Spencer, W. H., Spirito, P., Ten Cate, F. J., et al. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00941-0 · Cited by 1,578
Coronary Microvascular Dysfunction
Crea, F., Lanza, G. A., & Camici, P. G. (2014) · Springer eBooks · doi:10.1007/978-88-470-5367-0 · Cited by 1,287
Self-citation2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy
Gersh, B. J., Maron, B. J., Bonow, R. O., Dearani, J. A., Fifer, M. A., Link, M. S., Naidu, S. S., Nishimura, R. A., Ommen, S. R., Rakowski, H., et al. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.06.011 · Cited by 1,276
Metadata
- Authors
- Cecchi, F., Olivotto, I., Gistri, R., Lorenzoni, R., Chiriatti, G., & Camici, P. G.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2003-09-11
- Volume
- 349
- Issue
- 11
- Pages
- 1027-1035
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2120293113
- Cited by
- 782
- References
- 33
- FWCI
- 15.50
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.